A recent controversy has reignited debate over the safety of Tylenol for pregnant women after a tweet from the company resurfaced following comments by President Donald Trump. Trump sparked widespread attention when he asserted, without scientific evidence, that taking the painkiller while pregnant could be linked to autism.
At a press briefing, he emphatically warned expecting mothers, saying, “Don’t take Tylenol. Don’t take it. Fight like hell not to take it.” His statements quickly drew scrutiny from health experts and the media, especially given the well-established use of paracetamol—known in the U.S. as acetaminophen—as a standard pain relief medication during pregnancy.
In response to the claims, Kenvue, the parent company behind Tylenol, issued a strong rebuttal. They emphasized that any suggestion that Tylenol causes autism is unfounded and expressed concern over the potential harm such claims could cause to pregnant women seeking reliable medical guidance.
The company stated that acetaminophen remains one of the safest options for managing pain and discomfort during pregnancy, provided it is taken according to medical advice. Kenvue also noted that the misinformation could create unnecessary fear, highlighting the importance of consulting healthcare professionals before taking any medication.
The controversy was further fueled by a 2017 tweet from a Tylenol-associated account, which suggested that the brand did not recommend using its products during pregnancy. The tweet, originally a response to a now-deleted query, stated, “We actually don’t recommend using any of our products while pregnant. Thank you for taking the time to voice your concerns today.”
The tweet resurfaced amid Trump’s remarks and was quickly circulated by political supporters as proof that the former president’s warnings were justified. However, Kenvue clarified that the eight-year-old consumer response was incomplete and did not represent the company’s full guidance on the safe use of Tylenol. They underscored that acetaminophen is widely regarded by medical professionals as the first-line treatment for pain and fever in pregnant women.
Medical authorities, including the UK Department of Health and Social Care, continue to recommend paracetamol as the safest pain relief option for expectant mothers. Evidence suggesting a link between acetaminophen and neurodevelopmental disorders is limited and contested. A research review published in August raised concerns about fetal exposure potentially increasing the likelihood of autism spectrum disorders, but a 2024 study contradicted these findings, concluding there is no credible evidence linking Tylenol to autism.
The Royal Pharmaceutical Society reinforced that acetaminophen has been used safely by millions over decades and remains the preferred choice for managing pain across various patient groups, including pregnant women, children, and the elderly.The incident also brought attention to the broader spread of medical misinformation and the role social media plays in amplifying outdated or incomplete statements.
While the 2017 tweet was relatively minor at the time, its reemergence illustrates how quickly content can be reframed and weaponized in political debates, even years after its original posting. The White House’s official account reposted the old message alongside images of Trump, further complicating public understanding and creating a perception of validation for his claims.
Experts stress that expecting mothers should not make healthcare decisions based on viral social media posts or politically charged statements. While acetaminophen is generally safe when used as directed, overuse or unsupervised intake of any medication during pregnancy carries risks.
Health professionals recommend discussing any drug use with a doctor to ensure both the mother’s and the fetus’s safety. Kenvue’s response also reminded the public that the social media account in question had been inactive since 2021, and they could not confirm its ongoing affiliation with the company.
The episode underscores the challenges in separating scientific guidance from misinformation, especially when statements come from high-profile figures. Even well-intentioned warnings can cause alarm when presented without context or backed by incomplete evidence.
In this case, Kenvue and other health authorities worked to clarify the facts, reiterating that acetaminophen remains a safe and effective painkiller for pregnant women and that any medical decisions should be made in consultation with qualified professionals.
Overall, the resurfacing of the tweet and Trump’s comments highlight the ongoing tension between social media narratives, political influence, and public health information. While debates about the safety of medications during pregnancy are not new, this incident emphasizes the need for accurate, evidence-based guidance.
Pregnant women are encouraged to rely on medical advice from doctors and trusted health organizations rather than anecdotal claims or viral posts. By prioritizing verified information, expecting mothers can make informed choices that safeguard their health and that of their unborn children, avoiding unnecessary fears prompted by misinformation circulating online.
This situation also serves as a reminder of how historical statements from corporations or individuals can resurface, influencing public opinion long after their initial publication. The conversation surrounding Tylenol, autism, and pregnancy illustrates the complexities of public health communication in the digital age, where context and nuance are often lost amid sensational headlines and rapid information sharing.
